A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)
pharmaand GmbH
Bradley J Monk; Christine Parkinson; Myong Cheol Lim; David M O'Malley; Ana Oaknin; Michelle K Wilson; Robert L Coleman; Domenica Lorusso; Paul Bessette; Sharad Ghamande; Athina Christopoulou; Diane Provencher; Emily Prendergast; Fuat Demirkiran; Olga Mikheeva; Oladapo Yeku; Anita Chudecka-Glaz; Michael Schenker; Ramey D Littell; Tamar Safra; Hung-Hsueh Chou; Mark A Morgan; Vít Drochýtek; Joyce N Barlin; Toon Van Gorp; Fred Ueland; Gabriel Lindahl; Charles Anderson; Dearbhaile C Collins; Kathleen Moore; Frederik Marme; Shannon N Westin; Iain A McNeish; Danny Shih; Kevin K Lin; Sandra Goble; Stephanie Hume; Keiichi Fujiwara; Rebecca S Kristeleit
Biostatistics, Clovis Oncology Inc, Boulder, CO.